Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$64.89 USD
-0.36 (-0.55%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $64.90 +0.01 (0.02%) 7:32 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 361 - 380 ( 525 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 28
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 7
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended July 31
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended July 17
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended June 12This report contains brief updates on the following: ANAC, IRWD, GILD, XNPT, MNKD, ABBV, CELG. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Zacks Earning Trends: Retail Sector in the Spotlight, companies mentioned- M, WBA, AMZN, GILD, AAPL
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Zacks Earning Trends: Standout Sectors of Q1 Earnings Season, companies mentioned- WBA, AMZN, GILD, BAC, GS, JPM, AAPL, C
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D